Abstract

Obesity is correlated with significant human and social costs, an intransigent pandemic epidemic that is rising worldwide. At the same time, high obesity rates are known to decrease defense against pathogens. Around the same moment, high prevalence of obesity, considered to decrease defense against pathogens [1], are seen in patients with COVID-19 and particularly in those with metabolic syndrome associated with obesity. Even so, the correlation between decreased obesity and inadequate immune function and infection propensity presents significant issues about the likelihood of greater viral infectivity in this population [2]. The incidence of COVID-19 disease could also identify opportunities to body mass index [3]. A possible mechanism developed to describe this result is that elevated adiposity could compromise the pulmonary cell membrane in which a disordered loop of local inflammation, immune responses, and secondary injury is set up by the virus that tends to interfere with the host in this setting [4].